Related references
Note: Only part of the references are listed.Acclimation and Institutionalization of the Mouse Microbiota Following Transportation
Dan R. Montonye et al.
FRONTIERS IN MICROBIOLOGY (2018)
Liver - guardian, modifier and target of sepsis
Pavel Strnad et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression
Audrie A. Medina-Colorado et al.
PLOS ONE (2017)
Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis
Fei Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis
Carolin Fleischmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
A Novel Role for Programmed Cell Death Receptor Ligand-1 in Sepsis-Induced Intestinal Dysfunction
Youping Wu et al.
MOLECULAR MEDICINE (2016)
Effect of PD-1:PD-L1 in Invariant Natural Killer T-Cell Emigration and Chemotaxis Following Sepsis
John S. Young et al.
SHOCK (2016)
Identification of B7-H1 as a Novel Mediator of the Innate Immune/Proinflammatory Response as well as a Possible Myeloid Cell Prognostic Biomarker in Sepsis
Xin Huang et al.
JOURNAL OF IMMUNOLOGY (2014)
Kupffer Cells Protect Liver Sinusoidal Endothelial Cells from Fas-Dependent Apoptosis in Sepsis by Down-Regulating gp130
Noelle A. Hutchins et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States
David F. Gaieski et al.
CRITICAL CARE MEDICINE (2013)
Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1
Noelle A. Hutchins et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
IFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1
Stan de Kleijn et al.
PLOS ONE (2013)
INFLAMMATORY MECHANISMS IN SEPSIS: ELEVATED INVARIANT NATURAL KILLER T-CELL NUMBERS IN MOUSE AND THEIR MODULATORY EFFECT ON MACROPHAGE FUNCTION
Daithi S. Heffernan et al.
SHOCK (2013)
An in vivo Assay to Test Blood Vessel Permeability
Maria Radu et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
Raphael M. Zellweger et al.
CELL HOST & MICROBE (2010)
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
Yan Zhang et al.
CRITICAL CARE (2010)
IL-33 promotes DC development in BM culture by triggering GM-CSF production
Nobuyasu Mayuzumi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
Xin Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Management of sepsis in patients with liver failure
Juan M. Canabal et al.
CURRENT OPINION IN CRITICAL CARE (2008)
PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro
Wanhua Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: Distinct roles
Julia Menke et al.
JOURNAL OF IMMUNOLOGY (2007)
SOCS-1 is a central mediator of steroid-increased thymocyte apoptosis and decreased survival following sepsis
Chun-Shiang Chung et al.
APOPTOSIS (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Share Paper
